Related Experiment Video
Updated: Mar 7, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Treatment diary for botulinum toxin spasticity treatment: a pilot study
Bo Biering-Sørensen1, Helle K Iversen, Inge M S Frederiksen
1aSpasticity Clinic bStroke Unit cNeurological Clinic dClinic for Spinal Cord Injuries, Neuroscience Centre, Rigshospitalet, University of Copenhagen, Glostrup, Denmark.
This study developed a spasticity treatment diary to enhance patient involvement and goal setting. While patients reported satisfaction and better goal engagement, the diary did not significantly improve quality of life scores.
Area of Science:
- Rehabilitation Medicine
- Neurology
- Patient-Reported Outcomes
Background:
- Spasticity management often involves botulinum toxin injections and therapy.
- Effective patient engagement and goal setting are crucial for treatment success.
- A dedicated diary can potentially improve patient involvement in spasticity treatment.
Purpose of the Study:
- To develop and evaluate a treatment diary for patients undergoing spasticity treatment.
- To assess patient satisfaction and involvement in their treatment process.
- To measure the impact of the diary on goal attainment and quality of life.
Main Methods:
- Development of a comprehensive treatment diary for spasticity.
- Inclusion of patient self-evaluation and therapist evaluation using the Goal Attainment Scale.
- Administration of satisfaction questionnaires and quality of life measures (WHO-QoL BREF, WHO-5).
Main Results:
- Ten patients participated in the pilot study.
- Patients expressed general satisfaction with the diary, reporting increased involvement and easier goal setting.
- No significant improvements in quality of life scores (WHO-QoL BREF, WHO-5) were observed.
Conclusions:
- The developed treatment diary enhances patient engagement and goal setting in spasticity management.
- While beneficial for patient involvement, the diary's impact on quality of life requires further investigation.
- Future research should explore diary modifications to potentially improve well-being outcomes.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

